Telomeres consist of repeats of G-rich sequence at the end of chromosomes. These DNA repeats are synthesized by enzymatic activity associated with an RNA protein complex called telomerase. In most somatic cells, telomerase activity is insufficient, and telomere length decreases with increasing cell division, resulting in an irreversible cell growth arrest, termed cellular senescence. Cellular senescence is associated with an array of phenotypic changes suggestive of aging. Until recently, cellular senescence has largely been studied as an in-vitro phenomenon; however, there is accumulating evidence that indicates a critical role of telomere function in the pathogenesis of human atherosclerosis. This review attempts to summarize recent work in vascular biology that supports the`telomere hypothesis'. We discuss the possible relevance of telomere function to vascular aging and the therapeutic potential of telomere manipulation.
Introduction
Aging is a physiologic process associated with an increase in cardiovascular mobility and mortality even in the absence of known cardiovascular risk factors. Age-associated changes in the blood vessels include a decrease in compliance and an increase in in¯ammatory response that promote atherogenesis ( Fig. 1) [1]. It has also been reported that angiogenesis is impaired with advanced age [2] , whereas aging decreases the antithrombogenic property of the endothelium [3] . It has been suggested that age-related functional changes in vascular cells are responsible for these alterations [4, 5] . Endothelium-dependent vasodilation is impaired with age due to decreased production of vasodilators such as nitric oxide and prostacyclin in endothelial cells and reduced responsiveness to these vasodilators in vascular smooth muscle cells (VSMCs). Adrenergic, endothelium-independent VSMC vasodilation also declines with age. Moreover, increased expression of proin¯ammatory and prothrombogenic molecules was observed in vascular cells of aged arteries. It is noteworthy that similar functional changes have been reported in senescent vascular cells in vitro, as discussed later.
Cellular senescence is the limited ability of primary human cells to divide when cultured in vitro and accompanied by a speci®c set of phenotypic changes in morphology, gene expression and function. These changes in phenotype have been implicated in human aging [6] . This hypothesis, the cell hypothesis of aging, was ®rst described by Hay¯ick in 1960 and supported by evidence that cellular senescence and the division potential of human primary cultures are dependent on donor age and that the growth potential of cultures correlates well with mean maximum lifespan of the species from which the cultures are derived. Until recently, however, little attention has been paid to the potential impact of vascular cell senescence in vivo on age-related vascular disorders.
In the past few decades, signi®cant progress has been made in our understanding of the role of telomere in cellular senescence. This enables us to reassess the cell hypothesis of aging with regard to human vascular disorders. How might cellular senescence in vivo contribute to age-associated vascular diseases? Does telomere shortening in vivo promote vascular aging? In this review, we will describe recently accumulating evidence that supports the cell hypothesis of aging in the vasculature and discuss the potential involvement of cellular senescence induced by telomere shortening in the pathogenesis of human vascular disorders.
Vascular cell senescence in vivo
As is the case in human somatic cells, human vascular cells have a ®nite cell lifespan and eventually enter an irreversible growth arrest, cellular senescence. The histology of the lesions of human atherosclerosis has been extensively studied, and these studies have demonstrated that there are endothelial cells and VSMCs that exhibit the morphological feature of cellular senescence [7, 8] . Senescent-like endothelial cells are frequently found on the surface of atherosclerotic plaque, particularly in the regions of disturbed¯ow, whereas senescent-like VSMCs are detected in the intima of advanced lesions of atherosclerotic plaque. The in-vitro growth property of vascular cells derived from human atherosclerotic plaque is impaired, and they develop senescence earlier than those from normal lesions [9,10]. They also demonstrate the higher rates of apoptosis. In the aortic aneurysm, medial VSMCs reveal senescent-like morphology in culture and undergo earlier senescence compared with VSMCs from nonaneurysmal lesions [11] . These works on the morphology and growth properties of vascular cells in human atherosclerosis indicate the occurrence of cellular senescence in vivo. Recently, this notion has been con®rmed by cytochemical analysis in vivo using senescenceassociated b-galactosidase (SA b-gal) activity, a biomarker for cellular senescence originally discovered by Dimri et al. [12] . Human ®broblasts undergoing cellular senescence in vitro express increased activity of SA b-gal when assayed at pH 6, which is distinguishable from endogenous lysosomal b-gal activity that can be detected at pH 4. When applied to human dermal tissues from donors with an age range of 20±90 years, there is a clear correlation between the number of senescent (SA b-gal positive) cells and the age of donor tissue. Increased activity of SA b-gal was reported in senescent human vascular cells in vitro as well [13] . Fenton et al. Aging is associated with a decrease in vascular compliance as well as an increase in vascular inflammation, thereby promoting atherogenesis. Angiogenic and antithrombogenic properties of endothelial cells are also impaired with age. These alterations appear to be attributed to age-associated functional changes in vascular cells as discussed in the text. EC, endothelial cell; NO, nitric oxide; VSMC, vascular smooth muscle cell.
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CA IMA atherosclerotic plaque and identi®ed as endothelial cells, but no positive cells were observed in the internal mammary arteries from the same patients where atherosclerotic changes were minimally observed. In advanced plaque, however, SA b-gal positive VSMCs were detected in the intima but not the media (T. Minamino et al., unpublished data), which may represent extensive replication in the lesions, as observed in the arteries subjected to double denudation.
Vascular dysfunction associated with cellular senescence
A number of studies have reported that many of the changes in senescent vascular cell behavior are consistent with known changes seen in age-related vascular diseases. These changes associated with replicative senescence in vascular cells could be dependent on telomere attrition. The production of nitric oxide and endothelial nitric oxide synthase (eNOS) activity are reduced in senescent human endothelial cells [16] . Induction of nitric oxide production by shear stress is also decreased in senescent endothelial cells [17 . ]. A decline in eNOS activity is attributable to a decrease in expression of eNOS protein as well as in eNOS phosphorylation mediated by Akt [18 . ]. This reduction seems to be involved in the mechanism underlying enhanced sensitivity of senescent endothelial cells to apoptotic stimuli. The levels of prostacyclin production are decreased signi®cantly with in-vitro aging of endothelial cells [19], whereas senescent endothelial cells upregulate plasminogen activator inhibitor-1 [20]. All these alterations could account for the impairment of endotheliumdependent vasodilation but also increased sensitivity of thrombogenesis in human atherosclerosis and arteriosclerosis. Cellular senescence is known to stimulate monocyte binding to endothelial cells [21] . This appears to be mediated by upregulation of adhesion molecules and proin¯ammatory cytokines as well as a decrease in endothelial production of nitric oxide in senescent endothelial cells [15 . . ,17 . ]. Stimulation of senescent endothelial cells with proin¯ammatory cytokine exacerbates monocyte±endothelial cell interactions more profoundly. Higher levels of adhesion molecules and lower levels of eNOS were observed in SA b-gal positive endothelial cells of human atherosclerosis as well (T. Minamino et al., unpublished data). There is also evidence for senescence-associated functional changes in VSMCs. Responsiveness to nitric oxide and b-adrenoreceptor stimulation is decreased with invitro aging, which may contribute to the impairment of endothelium-dependent as well as independent vasodilation in aged arteries [1, 22] . The production of elastase elevates in senescent VSMCs as seen in aged arteries, which may be relevant to age-dependent modi®cation of extracellular matrix [23].
Telomere shortening in age-associated vascular diseases
Potential triggers and effectors of cellular senescence have been suggested. One widely discussed hypothesis is telomere hypothesis of senescence. Telomeres are nonnucleosomal DNA±protein complexes at the end of the chromosome that serve as protective caps and are substrates for specialized replication mechanisms. As a consequence of semi-conservative DNA replication, the extreme termini of chromosomes are not duplicated completely, resulting in successive shortening of telomeres with each cell division. Critically short telomere is thought to trigger the onset of cellular senescence. Thus, telomere shortening is proposed as a mitotic clock that prevents unlimited proliferation of human somatic cells.
Telomerase is a ribonucleoprotein that adds telomeres onto chromosome ends with its RNA moiety as a template. 
Effects of oxidative stress on telomere attrition
Oxidative stress has been implicated in human aging as well as cellular senescence [48] . Emerging data indicate a possible link between oxidative stress and telomere shortening in vascular cells. Homocysteine, one of the risk factors for atherosclerosis, increases the rates of telomere shortening and accelerates endothelial cell senescence [49] . Both are signi®cantly inhibited by the treatment with antioxidants. Oxidized LDL was reported to inactivate telomerase activity by inhibiting the phosphoinositol 3-kinase/Akt pathway in endothelial cells [50] . Inactivation of telomerase by oxidative stress also involves RanGTPase-dependent nuclear export of TERT [51]. Conversely, suppression of oxidative stress or hypoxia preserves telomere length and extends cell lifespan at least partially through telomerase activation [26 . ,52]. Nitirc oxide also activates telomerase and delays endothelial cell senescence. It is possible that nitric oxide reacts with cellular radicals and decreases oxidative stress, resulting in telomerase activation [53] .
Pathophysiological role of telomerase activity
Since early studies reported that telomerase activity was detected in cancer cells but not normal somatic cells, the idea emerged that telomerase activity might be essential for tumor growth [54] . Increasing evidence has suggested that telomerase activity may be involved in the regulation of cell proliferation in normal somatic cells as well [41] . Telomerase activity is primarily regulated by transcription levels of TERT but also by posttranscriptional modi®cations of TERT. The processes of transportation to the nucleus, assembly of the holoenzyme and recruitment of telomerase to telomeres are also implicated in the regulation of telomerase activity and telomere maintenance [55,56 . 
Conclusion
Telomere biology in the vasculature has begun recently and is still in its infancy. The recent demonstration that vascular cell senescence and telomere shortening occur in vivo with respect to vascular aging will provide new insights into vascular biology. In addition, the ®ndings of the ability of telomerase to immortalize vascular cells and to maintain a juvenile phenotype in vitro and in vivo will have an important impact on the future research in stem cell biology as well as tissue engineering, although it should be noted that telomerase activation in conjunction with additional genetic alterations could be tumorgenic [61] . Future challenges will be to develop experimental approaches for testing the importance of cellular senescence and telomere shortening in vascular aging in vivo, and to determine whether reducing cellular senescence prevents us from age-associated vascular diseases.
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